&Partners’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672K Sell
12,743
-338
-3% -$17.8K ﹤0.01% 1528
2025
Q4
$691K Sell
13,081
-755
-5% -$40K ﹤0.01% 1440
2025
Q3
$735K Buy
13,836
+3,264
+31% +$173K ﹤0.01% 1239
2025
Q2
$560K Buy
+10,572
New +$557K ﹤0.01% 1298

Other funds holding CLOI

&Partners's CLOI Position: Q1 2026 in Review

&Partners reduced its VanEck CLO ETF (CLOI) stake by 2.6% in Q1 2026, selling an estimated $17.8K and leaving 12,743 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

&Partners first reported a position in CLOI in Q2 2025 and has held it in 4 quarters since. The position peaked at $735K in Q3 2025. 167 funds tracked by Wall St. Rank hold CLOI as of Q1 2026.

  • &Partners held 12,743 shares of VanEck CLO ETF worth $672K as of Q1 2026.
  • &Partners sold 338 VanEck CLO ETF shares in Q1 2026, an estimated $17.8K.
  • VanEck CLO ETF made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1528 holding.
  • &Partners first reported a position in VanEck CLO ETF in Q2 2025 and has held it in 4 quarters since.
  • &Partners's VanEck CLO ETF position peaked at $735K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.